D5 - Better outcomes for hepatitis C patients in your community


Organised by the FIP Community Pharmacy Section in collaboration with the FIP Academic Pharmacy Section


Manjiri Gharat (Indian Pharmaceutical Association, India) and Julie Akers (Washington State University, College of Pharmacy, USA)


09:00 – 09:10 Introduction by the chairs

  1. 09:10 – 09:45 Overview of the worldwide hepatitis C landscape
    Antons Mozalevskis (WHO Regional Office Europe, World Health Organization)
  2. 09:45 – 10:20 Utilisation of pharmacists as patient care providers for hepatitis C patients
    Julie Akers (College of Pharmacy, WSU, USA)

 10:20 – 10:40 Coffee/tea break 

  1. 10:40 – 11:15 Implementing innovative patient care training in pharmacy education
    Patricia Acuña Johnson (University of Valparaiso, Chile)
  2. 11:15 – 11:50 Pharmacist-provided patient care services on a global scale
    Peter Guthrey (Pharmaceutical Society of Australia, Australia)

11:50 – 12:00 Conclusion by the chairs

Learning Objectives

At the end of this session, participants will be able to:

  1. Describe why hepatitis C is a global concern;
  2. Define the many practice settings in which pharmacists are involved in patient care for those with hepatitis C;
  3. Outline policy development and solutions to barriers to implement patient care services;
  4. Identify key variations among pharmacy practice worldwide and how it affects a cohesive effort toward innovation.

Type of session: Knowledge-based